Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

Don’t see coverage of an asset you’re looking for? Let us know and we’ll add it to future snacks.

ConocoPhillips recently outperformed the broader market, closing 2.12% higher while the S&P 500 gained only 0.8%. The company ...

Nike will raise U.S. shoe prices after a rough Q4 showing a 14% drop in direct sales and a brutal 26% crash in online sales.

Philip Morris stock took a 2.7% dive, sparking debate on whether this is a bargain entry or the start of a slump. The stock ...

Sava Infond d.o.o. increased its position in Lam Research by 19.3% in Q1, raising its total holdings to 73,000 shares. This ...

Intuitive Surgical's stock slipped 1.27% to $522.86, continuing a short-term downward trend that spans the past month and ...

Goldman Sachs is basking in the glow of institutional love, with billions in capital rushing in after a blockbuster earnings ...

UPS trades at a premium valuation, boasting a forward P/E of 13.15X—above industry averages and its main rival. The company’s ...

Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting ...

Invesco LLC significantly increased its stake in Honeywell International by 122% during the first quarter, reflecting growing ...

RTX Corporation’s stock dropped 3.2% during Tuesday’s trading, even as analysts remained largely bullish with upgraded price ...